These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 14707802)

  • 1. Gynecomastia, lipodystrophy syndrome, and dyslipidemia occurring or worsening during antiretroviral regimens other than protease inhibitor-based ones.
    Manfredi R; Calza L; Chiodo F
    J Acquir Immune Defic Syndr; 2004 Jan; 35(1):99-102. PubMed ID: 14707802
    [No Abstract]   [Full Text] [Related]  

  • 2. Another emerging event occurring during HIV infection treated with any antiretroviral therapy: frequency and role of gynecomastia.
    Manfredi R; Calza L; Chiodo F
    Infez Med; 2004 Mar; 12(1):51-9. PubMed ID: 15329529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors.
    Carr A; Samaras K; Burton S; Law M; Freund J; Chisholm DJ; Cooper DA
    AIDS; 1998 May; 12(7):F51-8. PubMed ID: 9619798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efavirenz-associated gynecomastia: report of five cases and review of the literature.
    Jover F; Cuadrado JM; Roig P; Rodríguez M; Andreu L; Merino J
    Breast J; 2004; 10(3):244-6. PubMed ID: 15125753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic complications of HIV therapy in children.
    McComsey GA; Leonard E
    AIDS; 2004 Sep; 18(13):1753-68. PubMed ID: 15316336
    [No Abstract]   [Full Text] [Related]  

  • 6. Bilateral lipomastia in men: a side effect of highly active antiretroviral therapy.
    Deonarain J; Ramdial PK; Singh B
    Int J Surg Pathol; 2008 Apr; 16(2):171-5. PubMed ID: 18417674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiovascular risk factors associated with antiretroviral therapy].
    Pérez-Camacho I; Camacho A; Torre-Cisneros J; Rivero A
    Enferm Infecc Microbiol Clin; 2009 Sep; 27 Suppl 1():24-32. PubMed ID: 20172412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simplified regimens for treating HIV infection and AIDS.
    Piliero PJ; Colagreco JP
    J Am Acad Nurse Pract; 2003 Jul; 15(7):305-12. PubMed ID: 12929251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gynaecomastia associated with saquinavir therapy.
    Donovan B; Bodsworth NJ; Mulhall BP; Allen D
    Int J STD AIDS; 1999 Jan; 10(1):49-50. PubMed ID: 10215131
    [No Abstract]   [Full Text] [Related]  

  • 10. Lipodystrophic syndromes and hyperlipidemia in a cohort of HIV-1-infected patients receiving triple combination antiretroviral therapy with a protease inhibitor.
    Rakotoambinina B; Médioni J; Rabian C; Jubault V; Jais JP; Viard JP
    J Acquir Immune Defic Syndr; 2001 Aug; 27(5):443-9. PubMed ID: 11511820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic effects of protease inhibitor therapy.
    Bernasconi E
    AIDS Read; 1999 Jul; 9(4):254-6, 259-60, 266-9. PubMed ID: 12737115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gynecomastia without lipodystrophy syndrome in HIV-infected men treated with efavirenz.
    Caso JA; Prieto Jde M; Casas E; Sanz J
    AIDS; 2001 Jul; 15(11):1447-8. PubMed ID: 11504970
    [No Abstract]   [Full Text] [Related]  

  • 13. Cutaneous toxicities of antiretroviral therapy for HIV: part I. Lipodystrophy syndrome, nucleoside reverse transcriptase inhibitors, and protease inhibitors.
    Introcaso CE; Hines JM; Kovarik CL
    J Am Acad Dermatol; 2010 Oct; 63(4):549-61; quiz 561-2. PubMed ID: 20846563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Images in clinical medicine. Lipodystrophy induced by antiretroviral therapy.
    Warren SM; May JW
    N Engl J Med; 2005 Jan; 352(1):63. PubMed ID: 15635113
    [No Abstract]   [Full Text] [Related]  

  • 15. Lipodystrophy and metabolic disorders as complication of antiretroviral therapy of HIV infection.
    Holstein A; Plaschke A; Egberts EH
    Exp Clin Endocrinol Diabetes; 2001; 109(8):389-92. PubMed ID: 11748485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reviving protease inhibitors: new data and more options.
    Murphy RL
    J Acquir Immune Defic Syndr; 2003 Jun; 33 Suppl 1():S43-52; quiz S53, S55-6. PubMed ID: 12946064
    [No Abstract]   [Full Text] [Related]  

  • 17. Gynecomastia and HAART.
    Post JJ
    AIDS Read; 2000 May; 10(5):314. PubMed ID: 10851722
    [No Abstract]   [Full Text] [Related]  

  • 18. Gynaecomastia associated with combination antiretroviral therapy including protease inhibitors for human immunodeficiency virus infection.
    Post JJ
    Int J STD AIDS; 1999 Apr; 10(4):275-6. PubMed ID: 12035783
    [No Abstract]   [Full Text] [Related]  

  • 19. [HIV lipodystrophy syndrome: a new challenge to the endocrinologist].
    Valente O; Valente AM
    Arq Bras Endocrinol Metabol; 2007 Feb; 51(1):3-4. PubMed ID: 17435848
    [No Abstract]   [Full Text] [Related]  

  • 20. [Abnormal body fat distribution and type of antiretroviral therapy as predictors of cardiovascular disease risk in HIV-infected patients].
    Ena J; Benito C; Llácer P; Pasquau F; Amador C
    Med Clin (Barc); 2004 May; 122(19):721-6. PubMed ID: 15171905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.